Search research articles
Contact Us
Filters
Showing results (391-400 of 940) with videos related to
Page
of 94
Sort By:
Antibody Therapeutics
|
November 11, 2025
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase
Claudia Comacchio, Stefanie K Pfister, Domenico Ravazza, et al.
Journal of Neuro-Oncology
|
June 14, 2016
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma
Felicitas Strehlow, Sandra Bauer, Peter Martus, et al.
Neuro-Oncology
|
February 12, 2016
68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
Michael Sommerauer, Jan-Karl Burkhardt, Karl Frontzek, et al.
Scientific Reports
|
October 17, 2019
Lymphatic outflow of cerebrospinal fluid is reduced in glioma
Qiaoli Ma, Felix Schlegel, Samia B Bachmann, et al.
International Journal of Cancer
|
September 14, 2011
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper, Matthias Simon, Claus-Dieter Langhans, et al.
Journal of Neuro-Oncology
|
October 21, 2009
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
Delia Kurzwelly, Martin Glas, Patrick Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2008
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E Hegi, Lili Liu, James G Herman, et al.
Neuro-Oncology
|
May 28, 2010
Defective p53 antiangiogenic signaling in glioblastoma
Benjamin Berger, David Capper, Dieter Lemke, et al.
Scientific Reports
|
March 5, 2025
An effective MRI perfusion threshold based workflow to triage additional <sup>18</sup>F-FET PET in posttreatment high grade glioma
Krishna Ranjith Kadali, Nathalie Nierobisch, Fabienne Maibach, et al.
Pharmacoepidemiology and Drug Safety
|
July 21, 2011
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)
Markus Guzek, Olesya I Zorina, Alexander Semmler, et al.
Page
of 94
Search research articles
Search
Showing results (391-400 of 940) with videos related to
Sort By:
Page
of 94
Antibody Therapeutics
|
November 11, 2025
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase
Claudia Comacchio, Stefanie K Pfister, Domenico Ravazza, et al.
Journal of Neuro-Oncology
|
June 14, 2016
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma
Felicitas Strehlow, Sandra Bauer, Peter Martus, et al.
Neuro-Oncology
|
February 12, 2016
68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?
Michael Sommerauer, Jan-Karl Burkhardt, Karl Frontzek, et al.
Scientific Reports
|
October 17, 2019
Lymphatic outflow of cerebrospinal fluid is reduced in glioma
Qiaoli Ma, Felix Schlegel, Samia B Bachmann, et al.
International Journal of Cancer
|
September 14, 2011
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper, Matthias Simon, Claus-Dieter Langhans, et al.
Journal of Neuro-Oncology
|
October 21, 2009
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
Delia Kurzwelly, Martin Glas, Patrick Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2008
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E Hegi, Lili Liu, James G Herman, et al.
Neuro-Oncology
|
May 28, 2010
Defective p53 antiangiogenic signaling in glioblastoma
Benjamin Berger, David Capper, Dieter Lemke, et al.
Scientific Reports
|
March 5, 2025
An effective MRI perfusion threshold based workflow to triage additional <sup>18</sup>F-FET PET in posttreatment high grade glioma
Krishna Ranjith Kadali, Nathalie Nierobisch, Fabienne Maibach, et al.
Pharmacoepidemiology and Drug Safety
|
July 21, 2011
Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)
Markus Guzek, Olesya I Zorina, Alexander Semmler, et al.
Page
of 94